NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Categories: Independent research center news release


Can bone density scans help assess cardiovascular risk? More details needed in news release


Announcement on phase 1 leprosy vaccine trial suffers from hyperbole, lack of evidence


‘Magical’ with ‘superpowers’? This drug to fight antibiotic-resistant infection hasn’t been tested in animals or humans yet.


Fred Hutch oversells benefit of new fast-tracked drug for rare skin cancer

2 6/21/2016

It’s never OK to use ‘holy grail of breast cancer prevention’ when talking about pre-clinical animal study


Overly enthusiastic PR release claims breast cancer prevention is “within reach” based on animal, cell culture studies


News release makes claims about ketamine for depression based on thin evidence


Nutritional drink to protect memory in ‘early Alzheimer’s’? Release takes us for a spin

1 1/29/2016

Recycled PR release doesn’t tell us anything new about garlic


Possible new Parkinson’s drug — Novel: Yes. “Breakthrough”: No.